NeuroClimax™ Advanced – Nootropic Nasal Spray | 1-Month Supply

NeuroClimax™ Advanced — A Forskolin and Noopept Intranasal Formulation

Two principal compound groups. A distinct scientific approach. One proprietary NeuroClimax formulation.

NeuroClimax™ Advanced is a proprietary intranasal nootropic formulation developed by CNS Curative Technologies LLC.

The formulation features cyclic AMP (cAMP)-enhancing compounds, including forskolin, together with Noopept. These compounds have been investigated in scientific research involving neuronal signaling, neurotrophic pathways, synaptic plasticity, and mitochondrial biology.

Advanced differs from the NeuroClimax Gold formulations through its emphasis on cAMP-related signaling and its particular ingredient composition.

This product is presented as a one-month supply.

Scientific distinction: Research involving individual compounds and experimental formulations does not establish the clinical effectiveness or safety of the finished NeuroClimax Advanced product in humans.

What Makes NeuroClimax™ Advanced Different?

NeuroClimax Advanced brings together compounds with complementary scientific research backgrounds.

• Principal active compounds: cAMP-enhancing compounds, including forskolin, and Noopept.
• Scientific focus: Research involving cyclic AMP signaling, neuronal communication, and neurotrophic pathways.
• Delivery format: Proprietary intranasal spray.
• Product quantity: One-month supply.
• Formulation identity: Distinct from the kinetin-centered NeuroClimax Gold formulations.
• Developer: CNS Curative Technologies LLC.

The formulation reflects the company's research interests in biological processes associated with neuronal function.

Understanding the Active Ingredients

1. Forskolin and Cyclic AMP-Enhancing Compounds

Forskolin is a naturally occurring diterpene compound investigated for its ability to activate the enzyme adenylyl cyclase.

Adenylyl cyclase participates in the production of cyclic adenosine monophosphate (cAMP), an intracellular signaling molecule involved in numerous biological processes.

In neuroscience research, cAMP-related signaling has been studied in connection with:

• Neuronal communication and intracellular signaling.
• Synaptic plasticity.
• Learning and memory-related biological processes.
• Cellular metabolism.
• Neurotrophic signaling.
• Responses to cellular stress.

These biological relationships provide part of the scientific rationale for the development of NeuroClimax Advanced.

However, the known biochemical activity of forskolin does not independently establish the effects of the finished intranasal formulation.

2. Noopept and Neurotrophic Signaling

Noopept is a synthetic nootropic compound investigated in experimental research involving neuronal function, learning, memory-related processes, and neurotrophic signaling.

Preclinical investigations have examined its relationship with:

• Synaptic communication.
• Neurotrophic signaling.
• Glutamatergic neurotransmission.
• Neuronal plasticity.
• Learning and memory-related biological mechanisms.

Some experimental studies have investigated biological pathways involving brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF).

These proteins participate in important processes associated with neuronal development, maintenance, and communication.

The research provides scientific context for Noopept but does not demonstrate that NeuroClimax Advanced improves cognitive performance in humans.

The Scientific Foundation Behind NeuroClimax Advanced

cAMP, BDNF, and NGF Signaling

Neuronal function depends on interconnected biological signaling pathways that regulate communication, cellular responses, and the maintenance of neural networks.

Three important areas of neuroscience research relevant to the formulation are:

• Cyclic AMP (cAMP): An intracellular signaling molecule involved in cellular communication and several neuronal signaling pathways.
• Brain-Derived Neurotrophic Factor (BDNF): A protein involved in neuronal maintenance, development, and synaptic plasticity.
• Nerve Growth Factor (NGF): A neurotrophic factor involved in the development and maintenance of certain neuronal populations.

Research has examined relationships between these signaling systems and biological processes associated with neuronal survival, learning, and cellular responses to stress.

The development of NeuroClimax Advanced draws on this scientific background.

Mitochondrial Function and Neuronal Biology

Mitochondria participate in cellular energy production and other essential biological processes.

Scientific investigations have explored how mitochondrial function, oxidative stress, and neuronal signaling interact in healthy and experimental disease models.

These research areas contribute to the broader scientific foundation informing CNS Curative's development activities.

Findings involving cellular or animal models should not be interpreted as evidence that the commercial NeuroClimax Advanced formulation restores neuronal function or treats neurological disease in humans.

Published Preclinical Research

CNS Curative's scientific background includes published preclinical research investigating intranasal administration of forskolin and Noopept.

Intranasal Forskolin and Noopept Research

In a published study, Dagda and colleagues investigated an experimental intranasal formulation containing forskolin and Noopept in a PINK1-knockout rat model of Parkinsonian pathology.

The study examined motor behavior, neuronal changes, and biological signaling pathways associated with protein kinase A, BDNF, and NGF.

The researchers reported experimental findings relevant to neuronal signaling and neurodegeneration in the animal model.

Published reference:

Dagda, R.K., Dagda, R.Y., Vazquez-Mayorga, E., Martinez, B., and Gallahue, A. Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats. International Journal of Molecular Sciences. 2023;24(1):690.

Read the Published Scientific Study

Research limitation: This investigation involved experimental animals and a research formulation. Its findings do not establish the clinical safety, effectiveness, or therapeutic benefits of the finished commercial NeuroClimax Advanced product.

Understanding the Intranasal Delivery System

NeuroClimax Advanced uses a proprietary intranasal administration format.

Intranasal delivery is an area of pharmaceutical research because the nasal cavity provides an alternative route for administering certain compounds.

Researchers investigate intranasal delivery in relation to formulation properties, absorption, distribution, and potential applications involving the central nervous system.

However, the performance of an intranasal product depends on its complete formulation and supporting product-specific evidence.

The administration route alone does not establish rapid absorption, direct brain delivery, improved bioavailability, or clinical effectiveness.

Formulation Components

Principal Active Ingredients

According to CNS Curative's original product information, NeuroClimax Advanced includes:

• Forskolin and related cAMP-enhancing compounds: Investigated in research involving cyclic AMP signaling.
• Noopept: Investigated in research involving neuronal and neurotrophic signaling.

The company's original documentation also describes enhanced formulations that may contain centrophenoxine.

The inclusion and concentration of any additional active ingredient depend on the specific product formulation or batch and should be confirmed against current labeling.

Inactive Ingredients and Excipients

The original formulation information describes an excipient system intended to support solubility, stability, preservation, and intranasal administration.

Listed possible components include:

• Propylene glycol.
• Potassium or sodium sorbate.
• EDTA.
• Gamma-cyclodextrins.
• Sterile phosphate-buffered saline.

These are components identified in the company's existing documentation and do not constitute a verified, complete ingredient declaration for every production batch.

Customers should consult the current product label or contact CNS Curative Technologies for exact ingredient concentrations and formulation specifications.

How Does Advanced Compare with the NeuroClimax Gold Formulations?

The NeuroClimax product family includes formulations with different active ingredients and scientific research backgrounds.

NeuroClimax Advanced

Principal formulation focus: Forskolin, cAMP-enhancing compounds, and Noopept.

Developed around compounds investigated in relation to cyclic AMP activity and neurotrophic signaling.

NeuroClimax Gold (Max)

Active ingredients: Kinetin, Noopept, and centrophenoxine.

Combines three compounds investigated in research involving mitochondrial biology, neuronal signaling, and cognitive processes.

Explore NeuroClimax Gold (Max)

NeuroClimax Gold (Simple)

Active ingredient: Kinetin.

Provides a streamlined, single-active-ingredient formulation associated with research involving PINK1-related mitochondrial signaling.

Explore NeuroClimax Gold (Simple)

Important: These distinctions describe differences in ingredient composition and scientific background. They do not establish that one formulation is clinically superior, safer, or more effective than another.

Manufacturing and Quality Information

NeuroClimax products are developed, manufactured, and distributed by CNS Curative Technologies LLC, according to the company's published information.

CNS Curative describes manufacturing processes involving controlled sterile cleanroom environments and quality-control procedures.

The company's original product documentation references cleanroom specifications associated with ISO 14644-1:2015.

It also describes quality-control testing involving selected parameters such as:

• Ingredient purity.
• Formulation integrity.
• Microbiological contamination.
• Selected contaminants.

Specific facility classifications, certification status, batch testing, and sterility documentation should be verified against current supporting records.

Customers seeking detailed manufacturing or product-quality information can contact CNS Curative Technologies directly.

Patented Research and Intellectual Property

The scientific and technological background associated with CNS Curative includes intellectual property involving the investigation of nootropic agents and neurological disorders.

U.S. Patent No. US11612583B2

Patent title: Disease Modifying Methods for Treating Neurodegenerative Diseases Using Nootropic Agents.

Inventors: Raul Y. Dagda and Ruben K. Dagda.

Grant date: March 28, 2023.

Recorded assignee: Nevada Research & Innovation Corporation.

The patent describes methods involving nootropic compounds, including forskolin, in the context of neurological research and proposed therapeutic approaches.

The existence of a granted patent does not establish regulatory approval, clinical effectiveness, or authorization to market the finished NeuroClimax Advanced formulation for disease treatment.

Review the U.S. Patent Record

CNS Curative's original documentation also references a U.S. patent option agreement identified as NVRIC-OPTN-25-CNSCurative. The current status and scope of that agreement should be confirmed with the company.

National Science Foundation I-Corps Customer Discovery

According to CNS Curative's original product information, the company participated in customer-discovery activities supported through the National Science Foundation I-Corps program.

The reported activities involved discussions with prospective users, patients, caregivers, healthcare stakeholders, and other relevant groups.

Areas explored included:

• Unmet needs involving neurological and cognitive health.
• Patient and caregiver priorities.
• Challenges associated with existing approaches.
• Preferences regarding product delivery and usability.
• Potential applications of the underlying technology.

Customer-discovery activities provide commercial and development insights. They do not constitute independent clinical validation, regulatory approval, or an endorsement of the finished product by the National Science Foundation.

Before Ordering NeuroClimax Advanced

Review the product's current labeling, active and inactive ingredients, directions, warnings, and purchasing terms before making a decision.

If you have questions about the formulation, ingredient concentrations, manufacturing information, product suitability, or supporting scientific documentation, contact CNS Curative Technologies.

Seek advice from an appropriately qualified healthcare professional regarding individual medical considerations.

Current pricing, availability, and purchasing options are displayed separately on this product page.

Helpful customer information:

• Contact CNS Curative Technologies
• Shipping Information
• Returns and Refund Information

About CNS Curative Technologies

CNS Curative Technologies LLC
300 East 2nd Street
15th Floor, Suite 1512
Reno, Nevada 89501
USA

Company website: www.cnscurative.com

Online store: www.cnscurative.store

Important Scientific and Safety Information

The scientific information presented on this page includes published mechanistic and preclinical research involving individual compounds and experimental formulations.

Findings obtained from laboratory studies and animal models do not establish the clinical safety, effectiveness, appropriate dosing, or therapeutic benefits of the finished NeuroClimax Advanced product in humans.

Product-specific regulatory status, labeling, ingredient specifications, safety information, and marketing claims should be reviewed and approved by CNS Curative Technologies and appropriately qualified regulatory professionals.